Literature DB >> 29140133

ITE inhibits growth of human pulmonary artery endothelial cells.

Ling-Pin Pang1,2, Yan Li2, Qing-Yun Zou2, Chi Zhou2, Wei Lei1, Jing Zheng1,2, Shi-An Huang1.   

Abstract

AIM: Pulmonary arterial hypertension (PAH), a deadly disorder is associated with excessive growth of human pulmonary artery endothelial (HPAECs) and smooth muscle (HPASMCs) cells. Current therapies primarily aim at promoting vasodilation, which only ameliorates clinical symptoms without a cure. 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) is an endogenous aryl hydrocarbon receptor (AhR) ligand, and mediates many cellular function including cell growth. However, the roles of ITE in human lung endothelial cells remain elusive. Herein, we tested a hypothesis that ITE inhibits growth of human pulmonary artery endothelial cells via AhR.
MATERIALS AND METHODS: Immunohistochemistry was performed to localize AhR expression in human lung tissues. The crystal violet method and MTT assay were used to determine ITE's effects on growth of HPAECs. The AhR activation in HPAECs was confirmed using Western blotting and RT-qPCR. The role of AhR in ITE-affected proliferation of HPAECs was assessed using siRNA knockdown method followed by the crystal violet method.
RESULTS: Immunohistochemistry revealed that AhR was present in human lung tissues, primarily in endothelial and smooth muscle cells of pulmonary veins and arteries, as well as in bronchial and alveolar sac epithelia. We also found that ITE dose- and time-dependently inhibited proliferation of HPAECs with a maximum inhibition of 83% at 20 µM after 6 days of treatment. ITE rapidly decreased AhR protein levels, while it increased mRNA levels of cytochrome P450 (CYP), family 1, member A1 (CYP1A1) and B1 (CYP1B1), indicating activation of the AhR/CYP1A1 and AhR/CYP1B1 pathways in HPAECs. The AhR siRNA significantly suppressed AhR protein expression, whereas it did not significantly alter ITE-inhibited growth of HPAECs.
CONCLUSIONS: ITE suppresses growth of HPAECs independent of AhR, suggesting that ITE may play an important role in preventing excessive growth of lung endothelial cells.

Entities:  

Keywords:  Aryl hydrocarbon receptor; Growth; ITE; Pulmonary artery endothelial cells

Mesh:

Substances:

Year:  2017        PMID: 29140133      PMCID: PMC5909382          DOI: 10.1080/01902148.2017.1367868

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  33 in total

Review 1.  The aryl hydrocarbon receptor and its xenobiotic ligands: a fundamental trigger for cardiovascular diseases.

Authors:  J F Savouret; A Berdeaux; R F Casper
Journal:  Nutr Metab Cardiovasc Dis       Date:  2003-04       Impact factor: 4.222

2.  2,3,7,8-Tetrachlorodibenzo-p-dioxin differentially suppresses angiogenic responses in human placental vein and artery endothelial cells.

Authors:  Yan Li; Kai Wang; Qing-Yun Zou; Ronald R Magness; Jing Zheng
Journal:  Toxicology       Date:  2015-08-11       Impact factor: 4.221

3.  Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

Authors:  Steeve Provencher; Olivier Sitbon; Marc Humbert; Ségolène Cabrol; Xavier Jaïs; Gérald Simonneau
Journal:  Eur Heart J       Date:  2006-01-23       Impact factor: 29.983

4.  Benzo[a]pyrene inhibits angiogenic factors-induced alphavbeta3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells.

Authors:  Ching-Hao Li; Yu-Wen Cheng; Yao-Teng Hsu; Yu-Jeng Hsu; Po-Ling Liao; Jaw-Jou Kang
Journal:  Toxicol Sci       Date:  2010-09-27       Impact factor: 4.849

5.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation.

Authors:  Yan Li; Kai Wang; Yi-Zhou Jiang; Xin-Wen Chang; Cai-Feng Dai; Jing Zheng
Journal:  Cell Oncol (Dordr)       Date:  2014-11-18       Impact factor: 6.730

6.  2,3,7,8-Tetrachlorodibenzo-p-dioxin: failure to demonstrate toxicity in twenty-three cultured cell types.

Authors:  J C Knutson; A Poland
Journal:  Toxicol Appl Pharmacol       Date:  1980-07       Impact factor: 4.219

7.  Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaïci; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Vincent Cottin; Bruno Degano; Xavier Jaïs; David Montani; Rogério Souza; Gérald Simonneau
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

8.  Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (Review).

Authors:  Stephen Safe; Andrew McDougal
Journal:  Int J Oncol       Date:  2002-06       Impact factor: 5.650

9.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Authors:  Christiane A Opitz; Ulrike M Litzenburger; Felix Sahm; Martina Ott; Isabel Tritschler; Saskia Trump; Theresa Schumacher; Leonie Jestaedt; Dieter Schrenk; Michael Weller; Manfred Jugold; Gilles J Guillemin; Christine L Miller; Christian Lutz; Bernhard Radlwimmer; Irina Lehmann; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

10.  A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo.

Authors:  E C Henry; J C Bemis; O Henry; A S Kende; T A Gasiewicz
Journal:  Arch Biochem Biophys       Date:  2006-03-03       Impact factor: 4.013

View more
  3 in total

1.  Roles of aryl hydrocarbon receptor in endothelial angiogenic responses†.

Authors:  Yan Li; Chi Zhou; Wei Lei; Kai Wang; Jing Zheng
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

2.  Reduced expression of microRNA-199a-3p is associated with vascular endothelial cell injury induced by type 2 diabetes mellitus.

Authors:  Hui Wang; Zhengxia Wang; Qingbin Tang
Journal:  Exp Ther Med       Date:  2018-08-24       Impact factor: 2.447

Review 3.  Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases.

Authors:  Tao Yi; Jinxia Wang; Kaixi Zhu; Yaoliang Tang; Shian Huang; Xiaorong Shui; Yuanlin Ding; Can Chen; Wei Lei
Journal:  Biomed Res Int       Date:  2018-06-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.